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Abstract:  MDMA (3,4-methylenedioxymethamphetamine) is reportedly severely toxic to both dopamine (DA) and   
serotonin neurons. MDMA significantly reduces the number of DA neurons in the substantia nigra, but not in the nucleus 
accumbens, indicating that MDMA causes selective destruction of DA neurons in the nigrostriatal pathway, sparing the 
mesolimbic pathway. Parkinson’s disease (PD) is a neurodegenerative disorder of multifactorial origin. The pathological 
hallmark of PD is the degeneration of DA neurons in the nigrostriatal pathway. Mutations in the parkin gene are   
frequently observed in autosomal recessive parkinsonism in humans. Parkin is hypothesized to protect against neurotoxic 
insult, and we attempted to clarify the role of parkin in MDMA-induced hyperthermia, one of the causal factors of  
neuronal damage, using parkin knockout mice. Body temperature was measured rectally before and 15, 30, 45, and 60 min 
after intraperitoneal injection of MDMA (30 mg/kg) at an ambient temperature of 22 ± 2ºC. Significantly enhanced hyper-
thermia after MDMA injection was observed in heterozygous and homozygous parkin knockout mice compared with 
wildtype mice, suggesting that parkin plays a protective role in MDMA neurotoxicity. 
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INTRODUCTION 
  The amphetamine derivative 3,4-methylenedioxymet-
hamphetamine (MDMA) is abused by young adults despite 
its potentially neurotoxic effects and psychiatric complica-
tions. MDMA produces a rapid enhancement of serotonin 
and dopamine (DA) release in the brain [1, 2]. Administra-
tion of MDMA in mice is well known to produce acute hy-
perthermia and degeneration of striatal DA nerve terminals 
[3]. Recently, Granado and colleagues [4] reported that 
MDMA produces a significant decrease in the number of 
tyrosine hydroxylase (TH)-immunoreactive neurons in the 
substantia nigra. This decrease was accompanied by a dose-
dependent decrease in TH- and DA transporter (DAT)-
immunoreactivity in the striatum. MDMA significantly re-
duces TH- and DAT-immunoreactivity in the striatum, but 
not in the nucleus accumbens, indicating that MDMA causes 
selective destruction of DA neurons in the nigrostriatal 
pathway, sparing the mesolimbic pathway. The degree of 
long-term neurodegeneration produced by MDMA appears 
to be closely related to the magnitude of the hyperthermic 
response [5]. Attenuation of the hyperthermia alleviates 
MDMA-induced loss of striatal dopamine [3]. 
  Parkinson’s disease (PD) is the most common neurode-
generative movement disorder. The major pathological hall-
mark of PD is the degeneration of DAergic neurons in the 
substantia nigra that innervate the striatum. The major symp-
toms of PD include tremor, bradykinesia, cogwheel rigidity, 
and postural instability, which arise from the degeneration of  
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DAergic neurons in the substantia nigra. PD is a neurode-
generative disorder of multifactorial origin, and mutations in 
the gene encoding parkin, an E3 ubiquitin-protein ligase [6], 
are frequently observed in autosomal recessive parkinsonism 
in humans. The loss of parkin function has been suggested to 
result in aberrant accumulation of parkin substrate proteins 
[6]. Accumulation of these proteins has been postulated to 
confer toxicity to DAergic neurons in the substantia nigra 
[7]. 
  In the present study, we hypothesized that parkin protects 
against neurotoxic insult, and we attempted to clarify the role 
of parkin in MDMA-induced hyperthermia, one of the causal 
factors of neuronal damage, using parkin knockout mice. 
MATERIALS AND METHODS 
Mice 
  Wildtype, heterozygous, and homozygous parkin knock-
out mice were prepared from heterozygous/heterozygous 
parkin knockout mouse crosses (21-37 g, 12-29 weeks of 
age). Mice were housed in an animal facility maintained at 
22 ± 2ºC and 55 ± 5% relative humidity under a 12/12 h 
light/dark cycle with lights on at 8:00 a.m. Food and water 
were available ad libitum. All behavioral testing was con-
ducted during the light cycle. The experimental procedures 
and housing conditions were approved by the Institutional 
Animal Care and Use Committee of the Tokyo Institute of 
Psychiatry, and all animals were treated humanely in accor-
dance with our institutional animal experimentation guide-
lines. 
Body Temperature Measurement 
  Rectal temperature measurement was performed using a 
digital thermometer (BAT-12; Physitemp Instruments Inc., Enhanced Hyperthermia Induced by MDMA in Parkin Knockout Mice  Current Neuropharmacology, 2011, Vol. 9, No. 1    97 
Clifton, NJ, USA) with 0.1ºC accuracy and a rectal probe for 
mice (RET-3, Physitemp Instrument Inc.). Each mouse was 
lightly restrained by hand for approximately 20 s while the 
probe was inserted approximately 2 cm into the rectum and a 
steady reading was obtained. Body temperature was meas-
ured rectally before and 15, 30, 45, and 60 min after intrape-
ritoneal (i.p.) injection of MDMA (30 mg/kg) at an ambient 
temperature of 22 ± 2ºC. 
Drugs 
  MDMA was synthesized at Matsuyama University Col-
lege of Pharmaceutical Sciences and freshly dissolved in 
saline. MDMA and vehicle were administered in a volume of 
0.1 ml/10 g body weight. 
Statistical Analysis 
  Mean and standard error were calculated from the values 
of 12-17 subjects. Changes in body temperature were ana-
lyzed by repeated-measures analysis of variance (ANOVA) 
followed by Scheffe’s post hoc test. Baseline temperature 
and changes in body temperature areas-under-the-curve 
(AUC) were analyzed by one-way ANOVA and Scheffe’s 
post hoc test. 
RESULTS 
Baseline Body Temperature in Parkin Knockout Mice 
  Baseline body temperature was measured before MDMA 
injection at room temperature (22 ± 2ºC). No significant dif-
ference in baseline body temperature was observed among 
wildtype, heterozygous, and homozygous parkin knockout 
mice (Fig. 1). 
 
 
 
 
 
 
 
 
 
Fig. (1). No significant differences in baseline body temperature 
were observed among wildtype, heterozygous, and homozygous 
parkin knockout mice. Body temperature prior to MDMA injection 
did not significantly differ among genotypes. Baseline body tem-
perature was analyzed by one-way ANOVA (F2,55 = 0.629, p  = 
0.5369) at an ambient temperature of 22 ± 2ºC. 
No Sex Differences in MDMA-Induced Hyperthermia 
  Body temperature was measured 15, 30, 45, and 60 min 
after i.p. injection of MDMA (30 mg/kg) at an ambient tem-
perature of 22 ± 2ºC. No significant differences in MDMA-
induced hyperthermia were observed between males and 
females within each genotype (Fig. 2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (2). Similar MDMA-induced (30 mg/kg, i.p.) hyperthermia 
was observed in male and female mice within each genotype. Body 
temperature areas-under-the-curve were analyzed by repeated-
measures ANOVA. (A) Sex, F1,10 = 0.181, p = 0.6796; Time, F4,40 
= 4.741, p = 0.0032; Sex  Time interaction, F4,40 = 1.124, p = 
0.3587. (B) Sex, F1,27 = 0.134, p = 0.7170; Time, F4,108 = 62.705, p 
< 0.0001; Sex  Time interaction, F4,108 = 1.231, p = 0.3021. (C) 
Sex, F1,15 = 2.350, p = 0.1461; Time, F4,60 = 26.22, p < 0.0001; Sex 
 Time interaction, F4,60 = 2.059, p = 0.0974. 
Enhancement of MDMA-Induced Hyperthermia in 
Parkin Knockout and Heterozygous Mice 
  Body temperature gradually increased from baseline after 
MDMA injection in all genotype groups. MDMA signifi-
cantly enhanced hyperthermia from 15 to 45 min after injec-
tion in parkin knockout mice and from 45 to 60 min after 
injection in heterozygous mice compared with wildtype mice 
(Fig. 3A). MDMA produced hyperthermia, with a maximum 
increase of 0.9ºC (37.9ºC) 45 min after injection in wildtype 
mice, 1.7ºC (38.6ºC) 45 min after injection in heterozygous 
mice, and 1.9ºC (38.8ºC) 30 min after injection in parkin 
knockout mice. Body temperature AUC values reflected sig-
nificantly enhanced hyperthermia in parkin knockout and 
heterozygous mice compared with wildtype mice (Fig. 3B). 
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DISCUSSION 
  In the present study, significantly enhanced MDMA-
induced hyperthermia was observed in parkin knockout and 
heterozygous mice compared with wildtype mice (Fig. 3B). 
The enhanced MDMA-induced hyperthermia in parkin 
knockout mice supports the hypothesis that parkin protects 
against MDMA-induced neurotoxic insult. 
  Hyperthermia is one of the major symptoms of acute 
MDMA-induced toxicity, which has been shown to be af-
fected by body temperature [3]. MDMA produces a rapid 
enhancement of DA release in the striatum [1] and preoptic 
anterior hypothalamus [8]. MDMA-induced hyperthermia 
was blocked by a DA D1 receptor antagonist [9]. Moreover, 
both the hyperthermia and augmented DA levels in the pre-
optic anterior hypothalamus after i.p. MDMA injection were 
significantly reduced by pretreatment with a D1 antagonist 
[8]. Interestingly, Sato et al. (2006) [10] reported that D1 
receptor levels in the striatum in parkin knockout mice was 
higher than in wildtype mice, although no change in TH-
positive substantia nigra neurons was found in parkin knock-
out mice, and no significant decrease in DAT levels was 
observed in the striatum. Therefore, the enhanced MDMA-
induced hyperthermia observed in the present study may be 
attributable to increased levels of D1 receptors in parkin 
knockout mice. 
 Sato  et al. (2006) [10] also suggested that presynaptic 
neurons (i.e., DAergic neurons) are functionally impaired in 
parkin knockout mice. DA synthesis is significantly de-
creased and methamphetamine-induced DA release is re-
duced in parkin knockout mice. Considering that DAergic 
neurons in the substantia nigra are severely damaged in PD 
patients, the enhanced MDMA-induced hyperthermia in 
parkin knockout mice may be attributable to functional im-
pairment of DAergic neurons, although the relationship be-
tween hyperthermia and DAergic neuron dysfunction re-
mains to be elucidated. 
  Additionally, we found no significant difference in base-
line body temperature among wildtype, heterozygous, and 
homozygous parkin knockout mice (Fig. 1). These data sug-
gest that parkin does not play a crucial role in the system that 
maintains basal body temperature. 
  In conclusion, MDMA-induced hyperthermia was en-
hanced in parkin knockout and heterozygous mice compared 
with wildtype mice. Parkin is hypothesized to be critical for 
protecting DAergic neurons from toxic insult, and the pre-
sent results suggest that parkin plays a protective role against 
MDMA-induced DAergic neuron neurotoxicity. 
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ABBREVIATIONS 
ANOVA  =  Analysis of variance 
DA =  Dopamine 
DAT =  Dopamine  transporter 
MDMA =  3,4-methylenedioxymethamphetamine 
PD =  Parkinson’s  disease 
TH =  Tyrosine  hydroxylase 
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